Elevated expression of caveolin-1 in adenocarcinoma of the colon

American Journal of Clinical Pathology

Volumn 115, Issue 5, 2001, Pages 719-724

  Fine, S W ^a   Lisanti, M P ^a   Galbiati, F ^a   Li, M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Carcinogenesis; Caveolin; Colon

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL TRANSFORMATION; COLON ADENOCARCINOMA; COLON ADENOMA; COLON MUCOSA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ADENOMA; CAVEOLIN 1; CAVEOLIN 2; CAVEOLINS; COLON; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; SIGNAL TRANSDUCTION;

EID: 0035153475     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/YL54-CCU7-4V0P-FDUT     Document Type: Article

References (46)

1. Caveolae, caveolin and caveolin-rich membrane domains: A signalling hypothesis
2. Molecular and cellular biology of caveolae paradoxes and plasticities
3. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
4. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells: Caveolin cofractionates with dystrophin and dystrophin-associated glycoproteins
5. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
6. Cell-type and tissue-specific expression of caveolin-2: Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo
7. Mutational analysis of the properties of caveolin-1: A novel role for the C-terminal domain in mediating homotypic caveolin-caveolin interactions
8. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin
9. Src tyrosine kinases, G alpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin: Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases
10. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains
11. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1
12. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: Functional significance of the NOS caveolin binding domain in vivo
13. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity
14. Nitric oxide synthases: Which, where, how, and why?
15. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle: Identification of a novel caveolin scaffolding/inhibitory domain
16. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains
17. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae
18. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membranes
19. Expression and characterization of recombinant caveolin: Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes
20. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo
21. Elevated expression of caveolin is associated with prostate and breast cancer
22. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins: Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
23. Caveolin interaction with protein kinase C: Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide
24. Loss of heterozygosity in human primary prostate carcinomas: A possible tumor suppressor gene at 7q31.1
25. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer
26. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene
27. Localization of a tumour-suppressor gene associated with human oral cancer on 7q31.1
28. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
29. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
30. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker
31. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells
32. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells
33. A genetic model for colorectal tumorigenesis
34. Prevalence of ras gene mutations in human colorectal cancers
35. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma
36. Expression of the c-erbB-2 gene product (P185) at different stages of neoplastic progression in the colon
37. Expression of the myc gene family in different stages of human colorectal cancer
38. Localization of the gene for familial adenomatous polyposis on chromosome 5
39. Identification of a chromosome 18q gene that is altered in colorectal cancers
40. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
41. Clues to the pathogenesis of familial colorectal cancer
42. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis cancer
43. Mutation of a mutL homolog in hereditary colon cancer
44. Genetic alterations during colorectal-tumor development
45. Phosphorylation of caveolin by Src tyrosine kinases: The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo
46. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src/Cav1/Grb7 signaling cassette